Delivery Order SPE2DB22D3501-SPE2DB25FXN64
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,854.78 on September 15, 2025, for the supply of Sprycel 100 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is non-set-aside and is scheduled for completion by September 16, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,143.67 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing under a delivery order contract type and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The...
- The Defense Logistics Agency awarded a delivery order valued at $9,653.81 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract valued at $35,010.98. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed without set-aside designation. Performance of this pharmaceutical supply contract will be fulfilled from AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sprycel 20 mg tablets (quantity 60) with a contract value of $5,063.03 and a completion date of September 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, demonstrating the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,430.48 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a direct pharmaceutical procurement under a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $19,116.19 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Sprycel 100 mg, a pharmaceutical product for oncology treatment. This delivery order, issued on September 9, 2025, represents a firm fixed-price contract with a completion date of September 10, 2025, and carries no set-aside designation. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXN64Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $22,026.48 on September 26, 2025, for the supply of Sprycel 100 mg tablets in quantities of 30. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by September 29, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's performance under this delivery order contributes to its broader mandate to supply specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 9/26/25 |